During the 2nd National Cancer Research Institute (NCRI) AML Academy meeting, which took place on October 8–9, 2020, we spoke to Executive Steering Committee Member Navel Daver, MD Anderson Cancer Center, Houston, US, about new targeted therapies in AML.